Patients with type 2 diabetes often experience fatigue, which impacts their self-care and quality of life. There are few data supporting a relationship between fatigue and glucose homeostasis, but fatigue in type 2 diabetes has been associated with higher body mass index (BMI), depression, physical inactivity, sleep disturbances, and chronic low-grade inflammation. Although links between fatigue and inflammation are documented in other disease populations, little is known about inflammatory mechanisms specific to type 2 diabetes and associated treatment modalities for type 2 diabetes-related fatigue. Herein we review existing knowledge about fatigue in type 2 diabetes and potential pharmacologic and behavioral therapies.
Type 2 diabetes, fatigue, inflammation, patient-reported outcomes, symptoms, management
The authors have no conflicts of interest to declare.
July 19, 2012
reverses diabetes type 2 and hypothyroidism (🔴 ricotta) | reverses diabetes type 2 brochurehow to reverses diabetes type 2 for 2012-09-03T00:00:00
Cynthia Fritschi, PhD, RN, University of Illinois at Chicago College of the 1 last update 03 Jul 2020 Nursing (MC 802), 845 South Damen Avenue, Chicago, IL 60612, US. E: [email protected] Cynthia Fritschi, PhD, RN, University of Illinois at Chicago College of Nursing (MC 802), 845 South Damen Avenue, Chicago, IL 60612, US. E: [email protected]
Type 2 diabetes, fatigue, inflammation, patient-reported for 1 last update 03 Jul 2020 outcomes, symptoms, management Type 2 diabetes, fatigue, inflammation, patient-reported outcomes, symptoms, management
Patients with type 2 diabetes commonly experience fatigue, which may be incapacitating and adversely affect self-care regimens.1–7 Fatigue is a perplexing problem for healthcare providers.8 Wessely suggests that because fatigue is a non-specific and universal symptom, chronic fatigue is challenging to diagnose and treat.9 Fatigue researchers do not have a standardized definition, measurement approach, or diagnostic criteria. Diabetes-related fatigue is assumed to correlate with alterations in glucose homeostasis, but few data support this hypothesis.3,7,10,11 Fatigue in type 2 diabetes is associated with higher body mass index (BMI),1,7,12 the presence of comorbid conditions,7,13 depression,7 physical inactivity,1,7,14 sleep disturbances,1,15,16 and elevated cytokines.3,10 Fritschi and Quinn recently provided a detailed review of the correlates of fatigue in diabetes, including conflicting findings regarding the relationship between fatigue and glycemic control.8
Type 2 diabetes is a disorder associated with chronic low-grade inflammation.17,18 Type 2 diabetes and insulin resistance, especially among obese patients, were linked to an increased production of pro-inflammatory cytokines (e.g., tumour necrosis factor alpha [TNF-α], monocyte chemoattractant protein-1 [MCP-1], interleukin-1β [IL-1β], interleukin-6 [IL-6]) from immune cells as well as increased acute phase reactants (e.g., C-reactive protein [CRP]). Pro-inflammatory cytokines and CRP were associated with high fatigue levels10,11,19,20 and depression and sleep disturbances in a variety of diseases.21–24 There is a considerable gap in the literature, however, about the treatment of fatigue secondary to type 2 diabetes. Anti-inflammatory therapies may ameliorate fatigue with type 2 diabetes. Thus, our discussion of fatigue interventions will focus on the few available pharmacologic and behavioral interventions in patients with type 2 diabetes to impact inflammation and fatigue.
To view the full article in PDF or eBook formats, please click on the icons above.